ストックスクリーナーアプリを入手
13.00
3.63%
-0.49
アフターアワーズ：
14.70
1.70
+13.08%
前日終値:
$13.49
開ける：
$13.16
24時間の取引高:
3.38M
Relative Volume:
1.24
時価総額：
$1.49B
収益：
$631.73M
当期純損益:
$-239.78M
株価収益率:
-6.4356
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+4.50%
1か月 パフォーマンス:
+2.85%
6か月 パフォーマンス:
+60.49%
1年 パフォーマンス:
-21.69%
1日の値動き範囲:
$12.80
$13.36
1週間の範囲:
$12.44
$13.85
52週間の値動き範囲:
$6.78
$17.25
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.00 | 1.68B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
291.21 | 48.40B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
72.09 | 14.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
62.58 | 11.99B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.74 | 8.13B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.80 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | 開始されました | Piper Sandler | Neutral |
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com
10x Genomics: Q3 Earnings Snapshot - San Francisco Chronicle
10x Genomics Inc (TXG) Q3 2025 Earnings: EPS of -$0.22 Beats Est - GuruFocus
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
How geopolitical tensions affect 10x Genomics Inc. stockForecast Cut & Daily Profit Focused Screening - newser.com
Can 10x Genomics Inc. stock resist market sell offsQuarterly Earnings Report & Daily Oversold Bounce Ideas - fcp.pa.gov.br
Vanguard Group Inc's Strategic Acquisition of 10x Genomics Inc S - GuruFocus
Advanced analytics toolkit walkthrough for 10x Genomics Inc.2025 Market Outlook & Weekly High Momentum Picks - newser.com
Is 10x Genomics Inc. stock attractive for income investorsMarket Rally & Low Risk Entry Point Tips - fcp.pa.gov.br
Is 10x Genomics Inc. stock a buy before product launchesTrade Risk Summary & Fast Exit and Entry Strategy Plans - newser.com
10x Genomics Earnings: What To Look For From TXG - Markets Financial Content
10X Genomics Hits Day High with 9.65% Surge in Intraday Performance - Markets Mojo
Can a trend reversal in 10x Genomics Inc. lead to recoveryInsider Selling & AI Enhanced Trading Alerts - newser.com
10x Genomics Inc. stock outlook for YEARWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com
Simon Quick Advisors LLC Makes New Investment in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe investment in uncertain marketsStop Loss & Daily Entry Point Trade Alerts - newser.com
Is 10x Genomics Inc. stock supported by strong fundamentalsJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Brighton Jones LLC Takes $263,000 Position in 10x Genomics $TXG - MarketBeat
25,103 Shares in 10x Genomics $TXG Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
10x Genomics (NASDAQ:TXG) Shares Up 10%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group, Inc. Adjusts Holdings in 10x Genomi - GuruFocus
Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard
ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus
10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma
10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan
Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - fcp.pa.gov.br
Canaccord Genuity Keeps Their Buy Rating on 10x Genomics (TXG) - The Globe and Mail
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - fcp.pa.gov.br
Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com
10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN
Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires Shares of 54,103 10x Genomics $TXG - MarketBeat
What momentum shifts mean for 10x Genomics Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Globe and Mail
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Motley Fool
Cookson Peirce & Co. Inc. Takes Position in 10x Genomics $TXG - MarketBeat
SPT Labtech and 10x Genomics Partner To Automate Single Cell Workflows - Technology Networks
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
2.59%
大文字化:
|
ボリューム (24 時間):